Keen Nicholas Insider Trading Activity

Average Profitability
<0.0001%
Insider Buys Quantity
0
Insider Buys Sum
$0
Insider Sells Quantity
16
Insider Sells Sum
$2.45M

Insider Activity of Keen Nicholas

Biography of Keen Nicholas

No biography is available at this moment.

2024-07-03SaleBicycle Therapeutics plc
BCYC
CHIEF SCIENTIFIC OFFICER
779
0.0018%
$19.64$15,300-25.56%
2024-04-03SaleBicycle Therapeutics plc
BCYC
CHIEF SCIENTIFIC OFFICER
790
0.0019%
$23.81$18,810-5.23%
2024-01-03SaleBicycle Therapeutics plc
BCYC
Chief Scientific Officer
2,640
0.0063%
$17.50$46,200+30.82%
2023-10-03SaleBicycle Therapeutics plc
BCYC
Chief Scientific Officer
272
0.0007%
$20.00$5,440+11.8%
2023-07-03SaleBicycle Therapeutics plc
BCYC
Chief Scientific Officer
336
0.0011%
$25.10$8,434-12.47%
2023-04-03SaleBicycle Therapeutics plc
BCYC
Chief Scientific Officer
319
0.001%
$21.11$6,734-0.23%
2023-01-03SaleBicycle Therapeutics plc
BCYC
Chief Scientific Officer
1,817
0.0059%
$29.06$52,802-27.23%
2021-10-05SaleBicycle Therapeutics plc
BCYC
Chief Scientific Officer
2,178
0.0087%
$45.10$98,228-8.41%
2021-10-01SaleBicycle Therapeutics plc
BCYC
Chief Scientific Officer
1,188
0.0048%
$45.00$53,460-6.33%
2021-09-16SaleBicycle Therapeutics plc
BCYC
Chief Scientific Officer
1,955
0.0079%
$45.01$87,995-4.52%
2021-09-15SaleBicycle Therapeutics plc
BCYC
Chief Scientific Officer
3,000
0.0123%
$45.00$135,000-3.35%
2021-09-02SaleBicycle Therapeutics plc
BCYC
Chief Scientific Officer
10,000
0.0392%
$40.00$400,000+4.26%
2021-07-14SaleBicycle Therapeutics plc
BCYC
Chief Scientific Officer
10,000
0.0413%
$35.00$350,000+25.5%
2021-03-31SaleBicycle Therapeutics plc
BCYC
Chief Scientific Officer
20,000
0.0835%
$30.00$600,000+40.84%
2021-03-15SaleBicycle Therapeutics plc
BCYC
Chief Scientific Officer
434
0.0019%
$28.00$12,152+42.99%
2021-03-12SaleBicycle Therapeutics plc
BCYC
Chief Scientific Officer
19,566
0.0905%
$28.50$557,534+44.94%
Total: 16
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.